[go: up one dir, main page]

MX2012007031A - Indoles e indolinas fusionadas al anillo amina de cabeza de puente utiles para tratar transtornos neurodegenerativos y neuropsiquiatricos. - Google Patents

Indoles e indolinas fusionadas al anillo amina de cabeza de puente utiles para tratar transtornos neurodegenerativos y neuropsiquiatricos.

Info

Publication number
MX2012007031A
MX2012007031A MX2012007031A MX2012007031A MX2012007031A MX 2012007031 A MX2012007031 A MX 2012007031A MX 2012007031 A MX2012007031 A MX 2012007031A MX 2012007031 A MX2012007031 A MX 2012007031A MX 2012007031 A MX2012007031 A MX 2012007031A
Authority
MX
Mexico
Prior art keywords
indolines
useful
treat neurodegenerative
amine ring
neuropsychiatry disorders
Prior art date
Application number
MX2012007031A
Other languages
English (en)
Inventor
William H Bunnelle
Lei Shi
Chih-Hung Lee
Michael R Schrimpf
Tao Li
Marc J Scanio
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2012007031A publication Critical patent/MX2012007031A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

La presente solicitud se refiere a derivados de indol e indolina de la fórmula (I), fórmula (ii), fórmula (III), o fórmula (IV), en donde a, R2, R3, h, k, m, n, L, Q, X, y Z son como se define en la especificación. La presente solicitud también se refiere a composiciones que comprenden dichos compuestos, y sus medicamentos para tratar trastornos de neurodegeneración y neuropsiquiátricos. (Ver Formula) .
MX2012007031A 2009-12-17 2010-12-14 Indoles e indolinas fusionadas al anillo amina de cabeza de puente utiles para tratar transtornos neurodegenerativos y neuropsiquiatricos. MX2012007031A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28754909P 2009-12-17 2009-12-17
US38228410P 2010-09-13 2010-09-13
PCT/US2010/060346 WO2011075487A1 (en) 2009-12-17 2010-12-14 Bridgehead amine ring -fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders

Publications (1)

Publication Number Publication Date
MX2012007031A true MX2012007031A (es) 2012-07-04

Family

ID=43567669

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007031A MX2012007031A (es) 2009-12-17 2010-12-14 Indoles e indolinas fusionadas al anillo amina de cabeza de puente utiles para tratar transtornos neurodegenerativos y neuropsiquiatricos.

Country Status (9)

Country Link
US (1) US8524703B2 (es)
EP (1) EP2516440B1 (es)
JP (1) JP5734999B2 (es)
CN (2) CN102781941B (es)
CA (1) CA2782361C (es)
ES (1) ES2512241T3 (es)
MX (1) MX2012007031A (es)
TW (1) TWI485152B (es)
WO (1) WO2011075487A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9625475B2 (en) * 2008-09-29 2017-04-18 Abbvie Inc. Indole and indoline derivatives and methods of use thereof
JP2012504137A (ja) 2008-09-29 2012-02-16 アボット・ラボラトリーズ インドール誘導体およびインドリン誘導体ならびにそれらの使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3239245A1 (de) * 1982-10-23 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln 5-ethyliden-1,4,5,6,7,8-hexahydro-7-methylen-2h-3,6-ethanoazonino/5,4-b/-indol, verfahren zur gewinnung und zur herstellung diese enthaltende pharmazeutische zubereitung
US5250537A (en) * 1992-03-13 1993-10-05 Scios Nova Inc. 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indole,-6,7,8,9,10-hexahydro-7,11-imino-5H-cyclooct[b]indole and substituted derivatives
US20050101623A1 (en) * 2003-07-23 2005-05-12 Pharmacia Corporation Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
ES2327940T3 (es) 2004-03-09 2009-11-05 Boehringer Ingelheim Pharmaceuticals Inc. 3-(4-heterociclil-1,2,3-triazol-1-il)-n-aril-benzamidas en calidad de inhibidores de la produccion de citocinas para el tratamiento de enfermedades inflamatorias cronicas.
GB0525672D0 (en) * 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0606147D0 (en) * 2006-03-28 2006-05-10 Bioniqs Ltd Method
US7915304B2 (en) 2006-10-24 2011-03-29 Congenia S.R.L. Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT
KR20100039862A (ko) 2007-06-26 2010-04-16 아스트라제네카 아베 카텝신 ｋ 억제제로서 1-시아노사이클로프로필-유도체
US8546381B2 (en) * 2008-03-24 2013-10-01 Medivation Technologies, Inc. Bridged heterocyclic compounds and methods of use
JP2012504137A (ja) * 2008-09-29 2012-02-16 アボット・ラボラトリーズ インドール誘導体およびインドリン誘導体ならびにそれらの使用方法
WO2011003021A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof

Also Published As

Publication number Publication date
US8524703B2 (en) 2013-09-03
EP2516440A1 (en) 2012-10-31
ES2512241T3 (es) 2014-10-23
CN102781941B (zh) 2014-12-31
EP2516440B1 (en) 2014-07-23
CA2782361A1 (en) 2011-06-23
JP5734999B2 (ja) 2015-06-17
TW201130840A (en) 2011-09-16
CA2782361C (en) 2018-01-16
WO2011075487A1 (en) 2011-06-23
JP2013514364A (ja) 2013-04-25
TWI485152B (zh) 2015-05-21
CN102781941A (zh) 2012-11-14
CN104592233A (zh) 2015-05-06
US20110152248A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
NZ597517A (en) 5-fluoropyrimidinone derivatives
MY152062A (en) Indole derivatives as crth2 receptor antagonists
MX2009011205A (es) Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide.
MX2010001218A (es) Metodos y composiciones para tratamiento contra esquizofrenia mediante uso de terapia combinada de agentes antipsicoticos.
WO2008027812A3 (en) Imidazopyridine and imidazopyrimidine derivatives
NZ598972A (en) Spiro-indoline-piperidine derivatives as selective GPR-40 activators for treating diabetes
PH12015501199A1 (en) Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1
MY155626A (en) Organic compounds.
SG169989A1 (en) Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
MX2010003366A (es) Derivados de piperidina y piperazina para el tratamiento de tumores.
TW200942534A (en) Organic compounds
EA201071234A1 (ru) Производные изохинолинона в качестве nk3 антагонистов
WO2011008312A3 (en) Indole and indoline derivatives and methods of use thereof
WO2012033525A3 (en) P53-mdm2 antagonists
WO2010150211A3 (en) Use of derivatives of indoles for the treatment of cancer
MX2011008195A (es) Derivados de indol como agentes anticancer.
NZ597483A (en) N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
UA107334C2 (ru) Производные аминоэфиров алкалоидов и их лекарственные композиции
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
UA117020C2 (uk) Нові сполуки індолу і піролу, спосіб їх одержання і фармацевтичні композиції, що їх містять
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
UA101811C2 (en) Novel herbicides
TW200716517A (en) Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
MX2012002369A (es) Formas de anhidrato de un derivado de piridina.
MX2010004498A (es) Derivados de ciclohexenoamida y su uso como antagonistas de trpv1.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ABBVIE INC.

FG Grant or registration